These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 2808278)

  • 1. Idiopathic thrombocytopaenic purpura in patients during remission of Hodgkin's disease.
    Tahiliani RR; Banavali SD; Parikh PM; Charak BS; Nair CN; Saikia TK; Gopal R; Advani SH
    J Assoc Physicians India; 1989 Feb; 37(2):141-3. PubMed ID: 2808278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Idiopathic thrombocytopenic purpura in Hodgkin's disease--an early sign of a recurrence (author's transl)].
    Schmitt-Gräff A; Seeber S; Wetter O; Schmidt CG
    Dtsch Med Wochenschr; 1978 Nov; 103(46):1839-41. PubMed ID: 568541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
    Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
    Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic thrombocytopenic purpura and Hodgkin's disease: report of two cases and a review of the literature.
    Kirshner JJ; Zamkoff KW; Gottlieb AJ
    Am J Med Sci; 1980; 280(1):21-8. PubMed ID: 7191634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic thrombocytopenic purpura in Hodgkin's disease: a rare occurrence of no prognostic significance.
    Cohen JR
    Cancer; 1978 Feb; 41(2):743-6. PubMed ID: 564740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immune thrombocytopenia in Hodgkin's disease].
    Burghuber OC; Smolen J; Kühböck J
    Acta Med Austriaca; 1986; 13(2):55-9. PubMed ID: 3766088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and prognostic significance of idiopathic thrombocytopenic purpura in patients with Hodgkin's disease in complete hematological remission.
    Martinelli G; Zinzani PL; Magagnoli M; Vianelli N; Tura S
    Haematologica; 1998 Jul; 83(7):669-70. PubMed ID: 9718878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).
    Lazarus HM; Loberiza FR; Zhang MJ; Armitage JO; Ballen KK; Bashey A; Bolwell BJ; Burns LJ; Freytes CO; Gale RP; Gibson J; Herzig RH; LeMaistre CF; Marks D; Mason J; Miller AM; Milone GA; Pavlovsky S; Reece DE; Rizzo JD; van Besien K; Vose JM; Horowitz MM
    Bone Marrow Transplant; 2001 Feb; 27(4):387-96. PubMed ID: 11313668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of Hodgkin's disease and "idiopathic" thrombopenic purpura].
    Foa J; Duchamp C; Carcassonne Y
    Nouv Presse Med; 1978 Jan; 7(3):206. PubMed ID: 566434
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease.
    Wiernik PH; Dutcher JP; Einzig AI; Sparano J; Frank M; Friedenberg W
    Cancer J Sci Am; 1998; 4(4):254-60. PubMed ID: 9689984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of Hodgkin's disease with thrombocytopenic purpura, polyneuritis, and cytomegalovirus pneumopathy (author's transl)].
    Duhamel G; Moise A; Najman A; Gorin N; Mayaud C; Chatelet F; Burguière AM
    Ann Med Interne (Paris); 1979; 130(10):449-53. PubMed ID: 231396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
    Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
    Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Idiopathic thrombocytopenic purpura as the initial manifestation of Hodgkin's disease].
    Paz RA; Bolo H; Sanabria A
    Medicina (B Aires); 1980; 40(2):176-8. PubMed ID: 7191039
    [No Abstract]   [Full Text] [Related]  

  • 14. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune thrombocytopenic purpura in a child with Hodgkin's disease.
    Berberoğlu S; Sarialioğlu F; Akyüz C; Kutluk T; Büyükpamukçu M
    Turk J Pediatr; 1995; 37(3):289-92. PubMed ID: 7502371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
    Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
    Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of age on treatment results in children and adolescents with Hodgkin's disease].
    Balwierz W; Moryl-Bujakowska A; Depowska T; Klekawka T; Stanuch H; Matysiak M; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Raś M; Sońta-Jakimczyk D; Moszant A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Drozyńska E; Wysocki M; Kołtan A; Krawczuk-Rybak M; Stolarska M
    Przegl Lek; 2004; 61 Suppl 2():40-4. PubMed ID: 15686044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
    Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine cases.
    Zarate-Osorno A; Medeiros LJ; Kingma DW; Longo DL; Jaffe ES
    Am J Surg Pathol; 1993 Feb; 17(2):123-32. PubMed ID: 8422110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.